Connect Biopharma Holdings Limited (CNTB) Stock Analysis

Company Overview

The market values Connect Biopharma Holdings Limited (CNTB) at $115.87M. The company sits in the Healthcare sector, in the Biotechnology industry. The company reports 64 employees.

The most recent close on file for CNTB is $1.84, dated September 4, 2026. That is −$0.09 (−4.66%) against the previous close. Over the past 52 weeks the price has ranged from $1.23 to $3.82. The latest close sits 49.59% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $64.00K. That is −99.75% against the prior fiscal year, when revenue was $26.03M. The same year closed with a net loss of $55.48M. The reported profit margin is 0%. Trailing earnings per share are −1.19.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $64.00K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 39.24 times revenue. On price-to-sales that is 157.08% above the Biotechnology median of 15.26. The medians here are taken across 656 Biotechnology companies that report the metric.

Daily returns over the trailing 5 years annualize to a volatility of 114.2%. Over the trailing twelve months the price has returned +3.37%. Across 5 years the annualized return works out at −40.63%.

Growth & Income

No dividend is on file for CNTB.

2026 is still running; the price is −34.75% year to date. Across the complete calendar years on file, 2025 returned +104.35% and 2022 returned −83.15%. Of the 4 complete calendar years on file, 3 finished higher.